Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ZIOP

Ziopharm

$3.89

0.03 (0.78%)

07:09
02/12/18
02/12
07:09
02/12/18
07:09
Hot Stocks
Ziopharm presents data on very rapid production of CAR T cells »

Ziopharm Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$3.46

-0.24 (-6.49%)

08:57
02/06/18
02/06
08:57
02/06/18
08:57
Hot Stocks
Ziopharm addresses rumors, stock volatility, backs guidance »

Ziopharm Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$4.28

-0.08 (-1.83%)

11:02
01/22/18
01/22
11:02
01/22/18
11:02
Periodicals
Ziopharm rise due to 'stupid money' inflow, Feuerstein says »

Adam Feuerstein tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ZIOP

Ziopharm

$4.20

-0.18 (-4.11%)

, BMY

Bristol-Myers

09:14
01/09/18
01/09
09:14
01/09/18
09:14
Hot Stocks
Ziopharm slides after pushing back start of pivotal cancer trial »

Shares of Ziopharm…

ZIOP

Ziopharm

$4.20

-0.18 (-4.11%)

BMY

Bristol-Myers

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 18

    Jan

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

VBLT

VBL Therapeutics

$7.30

0.25 (3.55%)

07:03
12/27/17
12/27
07:03
12/27/17
07:03
Hot Stocks
VBL Therapeutics enrolls first patient in Phase 3 Study of VB-111 »

VBL Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$6.65

-0.05 (-0.75%)

17:08
12/18/17
12/18
17:08
12/18/17
17:08
Syndicate
Breaking Syndicate news story on VBL Therapeutics »

VBL Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$6.70

-0.1 (-1.47%)

09:06
12/18/17
12/18
09:06
12/18/17
09:06
Hot Stocks
VBL says new biomarker data support VB-111's clinical effect »

VBL Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$3.68

-0.3 (-7.54%)

, ABLX

Ablynx

$23.93

0.01 (0.04%)

04:55
12/12/17
12/12
04:55
12/12/17
04:55
Conference/Events
American Society of Hematology to hold annual meeting »

59th ASH Annual Meeting…

RIGL

Rigel Pharmaceuticals

$3.68

-0.3 (-7.54%)

ABLX

Ablynx

$23.93

0.01 (0.04%)

ATNM

Actinium Pharmaceuticals

$0.69

-0.01 (-1.43%)

REGN

Regeneron

$381.32

0.54 (0.14%)

ONTX

Onconova

$1.37

-0.1097 (-7.41%)

KURA

Kura Oncology

$13.85

-1.05 (-7.05%)

IMGN

ImmunoGen

$6.18

-0.02 (-0.32%)

JUNO

Juno Therapeutics

$50.24

-8.41 (-14.34%)

BLCM

Bellicum Pharmaceuticals

$9.16

-0.37 (-3.88%)

BGNE

BeiGene

$91.39

-4.59 (-4.78%)

CBIO

Catalyst Biosciences

$8.31

0.77 (10.21%)

GBT

Global Blood Therapeutics

$44.78

-0.925 (-2.02%)

XLRN

Acceleron

$35.92

0.24 (0.67%)

ABBV

AbbVie

$96.47

0.52 (0.54%)

BMY

Bristol-Myers

$63.02

0.6 (0.96%)

EPZM

Epizyme

$12.85

-0.4 (-3.02%)

TGTX

TG Therapeutics

$8.25

-0.25 (-2.94%)

ALRN

Aileron Therapeutics

$10.16

0.01 (0.10%)

QURE

uniQure

$17.36

-0.46 (-2.58%)

PTLA

Portola Pharmaceuticals

$51.78

-1.24 (-2.34%)

ATRA

Atara Biotherapeutics

$14.50

-0.3 (-2.03%)

ZIOP

Ziopharm

$4.20

-0.23 (-5.19%)

STML

Stemline

$15.23

0.375 (2.53%)

KDMN

Kadmon

$3.55

-0.09 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

  • 08

    Jan

  • 18

    Jan

  • 30

    Jan

  • 02

    Feb

  • 05

    Mar

  • 17

    Apr

RIGL

Rigel Pharmaceuticals

$3.98

0.1 (2.58%)

, ABLX

Ablynx

$23.92

0.43 (1.83%)

04:55
12/11/17
12/11
04:55
12/11/17
04:55
Conference/Events
American Society of Hematology to hold annual meeting »

59th ASH Annual Meeting…

RIGL

Rigel Pharmaceuticals

$3.98

0.1 (2.58%)

ABLX

Ablynx

$23.92

0.43 (1.83%)

ATNM

Actinium Pharmaceuticals

REGN

Regeneron

$380.78

7.17 (1.92%)

ONTX

Onconova

$1.48

0.0322 (2.22%)

KURA

Kura Oncology

$14.90

0.75 (5.30%)

IMGN

ImmunoGen

$6.20

0.15 (2.48%)

JUNO

Juno Therapeutics

$58.65

1.92 (3.38%)

BLCM

Bellicum Pharmaceuticals

$9.53

0.32 (3.47%)

BGNE

BeiGene

$95.98

-0.24 (-0.25%)

CBIO

Catalyst Biosciences

$7.54

0.39 (5.45%)

GBT

Global Blood Therapeutics

$45.70

1.85 (4.22%)

XLRN

Acceleron

$35.68

0.58 (1.65%)

ABBV

AbbVie

$95.95

1.71 (1.81%)

BMY

Bristol-Myers

$62.42

0.58 (0.94%)

EPZM

Epizyme

$13.25

0.25 (1.92%)

TGTX

TG Therapeutics

$8.50

0.25 (3.03%)

ALRN

Aileron Therapeutics

$10.15

0.05 (0.50%)

QURE

uniQure

$17.82

0.8 (4.70%)

PTLA

Portola Pharmaceuticals

$53.02

0.31 (0.59%)

ATRA

Atara Biotherapeutics

$14.80

1.1 (8.03%)

ZIOP

Ziopharm

$4.43

0.09 (2.07%)

STML

Stemline

$14.85

-0.125 (-0.83%)

KDMN

Kadmon

$3.64

0.13 (3.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 14

    Dec

  • 08

    Jan

  • 18

    Jan

  • 30

    Jan

  • 02

    Feb

  • 05

    Mar

  • 17

    Apr

ZIOP

Ziopharm

$4.43

0.09 (2.07%)

, XON

Intrexon

$13.28

0.16 (1.22%)

17:48
12/10/17
12/10
17:48
12/10/17
17:48
Hot Stocks
Ziopharm announces presentation of data from T-Cell Therapy programs »

Ziopharm Oncology (ZIOP)…

ZIOP

Ziopharm

$4.43

0.09 (2.07%)

XON

Intrexon

$13.28

0.16 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.